Valuation: Treace Medical Concepts, Inc.

Market Cap 311M 277M 255M 232M 439M 29.14B 450M 3.05B 1.22B 15.6B 1.17B 1.14B 49.13B P/E 2026 *
-5.99x
P/E 2027 * -6.05x
Enterprise Value 355M 317M 292M 265M 502M 33.29B 514M 3.49B 1.39B 17.82B 1.33B 1.3B 56.14B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.77x
Free-Float
74.47%
Yield 2026 *
-
Yield 2027 * -
1 day+18.61%
1 week+11.94%
Current month+7.90%
1 month+21.01%
3 months+0.42%
6 months+137.81%
Current year+95.10%
1 week 3.42
Extreme 3.42
5.22
1 month 3.42
Extreme 3.42
5.25
Current year 1.17
Extreme 1.17
5.25
1 year 1.17
Extreme 1.17
5.25
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
27.97
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 65 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap. Importance
10/24/26 Tax

Responsable ventes & marketing

-207 0.0003%
9/30/26 Tax

Compliance Officer

-25,457 0.0391%
8/24/26 Buy

Chief Executive Officer

11,000 0.0170%
Change 5-day change 1-year change 3-year change Capi.($)
+18.61%+11.94%+7.05%-52.20% 311M
+0.53%+0.32%-12.54%+18.13% 191B
+0.97%+3.53%+11.49%+46.65% 126B
-0.04%+6.17%-8.51%+20.27% 124B
-1.65%+1.98%-38.20%+8.64% 98.14B
+3.66%+2.34%-4.14%+75.67% 65.98B
+1.59%+8.38%+21.04%-7.32% 58.63B
+4.53%+5.21%-0.25%+68.75% 55.67B
+1.66%-3.50%-5.76%+53.89% 48.78B
-0.13%+1.32%+3.73%-7.69% 36.03B
Average +2.97%+3.32%-2.61%+22.48% 80B
Weighted average by Cap. +0.90%+2.53%-6.16%+29.11%

Financials

2026 *2027 *
Net sales 208M 185M 171M 155M 294M 19.48B 301M 2.04B 814M 10.43B 780M 763M 32.84B 221M 197M 181M 164M 312M 20.68B 319M 2.17B 864M 11.07B 828M 810M 34.86B
Net income -51.81M -46.24M -42.55M -38.62M -73.19M -4.86B -75M -509M -203M -2.6B -194M -190M -8.19B -52.18M -46.57M -42.85M -38.89M -73.71M -4.89B -75.54M -513M -204M -2.62B -196M -192M -8.25B
Net Debt 44.31M 39.55M 36.39M 33.03M 62.6M 4.15B 64.15M 435M 174M 2.22B 166M 163M 7B 78.72M 70.26M 64.65M 58.68M 111M 7.38B 114M 773M 308M 3.95B 295M 289M 12.44B
Projected Income Statement - Annual - Treace Medical Concepts, Inc.
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-11-09 $4.780 +18.61% 1,094,543
26-11-06 $4.030 -3.59% 596,716
26-11-05 $4.180 -7.11% 323,314
26-11-04 $4.500 +5.14% 270,172
26-11-03 $4.280 +0.23% 211,636
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Treace Medical Concepts, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
4.780USD
Average target price
6.167USD
Spread / Average Target
+29.01%
  1. Stock Market
  2. Stocks
  3. TMCI Stock